Hepatitis B Surface Antigens
"Hepatitis B Surface Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
Below are MeSH descriptors whose meaning is more general than "Hepatitis B Surface Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B Surface Antigens".
This graph shows the total number of publications written about "Hepatitis B Surface Antigens" by people in Harvard Catalyst Profiles by year, and whether "Hepatitis B Surface Antigens" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 2 | 5 |
| 1995 | 3 | 3 | 6 |
| 1996 | 0 | 1 | 1 |
| 1997 | 3 | 1 | 4 |
| 1998 | 1 | 2 | 3 |
| 1999 | 1 | 2 | 3 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 1 | 2 |
| 2003 | 2 | 3 | 5 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 5 | 5 |
| 2010 | 3 | 3 | 6 |
| 2011 | 4 | 0 | 4 |
| 2012 | 3 | 4 | 7 |
| 2013 | 1 | 6 | 7 |
| 2014 | 3 | 3 | 6 |
| 2015 | 4 | 4 | 8 |
| 2016 | 2 | 5 | 7 |
| 2017 | 5 | 1 | 6 |
| 2018 | 4 | 6 | 10 |
| 2019 | 4 | 6 | 10 |
| 2020 | 5 | 4 | 9 |
| 2021 | 0 | 7 | 7 |
| 2022 | 2 | 14 | 16 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 2 | 2 |
Below are the most recent publications written about "Hepatitis B Surface Antigens" by people in Profiles.
-
HBV reactivation and clinical resolution in an isolated anti-HBc-positive patient during immune checkpoint inhibition. Med. 2024 Feb 09; 5(2):126-131.e1.
-
Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model. BMJ Open. 2024 01 12; 14(1):e073498.
-
Hepatitis B surface antigen loss in individuals with chronic hepatitis B virus and HIV-1 infections in Botswana. AIDS. 2024 Feb 01; 38(2):153-159.
-
High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana. J Infect Public Health. 2023 Nov; 16(11):1736-1741.
-
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus. Clin Infect Dis. 2023 08 14; 77(3):414-418.
-
Atypical Hepatitis B Virus Serology Profile-Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative-In Hepatitis B Virus/HIV Coinfected Individuals in Botswana. Viruses. 2023 07 13; 15(7).
-
Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia. J Viral Hepat. 2023 08; 30(8):700-709.
-
Use of HBV RNA and to predict change in serological status and disease activity in CHB. Hepatology. 2023 11 01; 78(5):1542-1557.
-
Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease. J Gastroenterol Hepatol. 2023 Jun; 38(6):989-998.
-
Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection. Hepatol Commun. 2023 04 01; 7(4).